Gastroenterology & Digestive Health

Irritable Bowel Syndrome (IBS)

IBS affects millions of people worldwide, causing abdominal discomfort, bloating, diarrhea, constipation, and changes in bowel habits. CenExel partners with sponsors to advance innovative IBS treatments through patient-focused clinical research across diverse populations.

Studies Conducted
0 +
Trial Participants
0 +
Active Centers
0
Overview

Advancing IBS Clinical Research

CenExel provides specialized expertise in Irritable Bowel Syndrome clinical trials, combining scientific precision with patient-centered care. Our experienced research teams support studies focused on IBS-D, IBS-C, mixed IBS, gut-brain interaction disorders, and emerging gastrointestinal therapies.

Improve Patient Outcomes

Our investigators focus on improving quality of life through innovative IBS treatment strategies and evidence-based research.

Accelerate Clinical Development

Dedicated psychiatric research teams and operational expertise help sponsors move programs forward efficiently.
Conditions Covered

IBS Conditions We Research

Our gastrointestinal research sites support a broad range of IBS-related conditions and digestive health disorders.

  • IBS with Constipation (IBS-C)
  • IBS with Diarrhea (IBS-D)
  • Mixed IBS (IBS-M)
  • Functional Abdominal Pain
  • Bloating & Gas Disorders
  • Chronic Constipation
  • Functional Dyspepsia
  • Gut-Brain Interaction Disorders
Our Approach

Why Sponsors Choose CenExel for IBS Research

CenExel combines scientific expertise, advanced recruitment strategies, and operational excellence to support IBS clinical trials from Phase I through Phase IV.

01

GI Research Expertise

Our experienced gastroenterology teams support complex IBS and digestive health studies with high-quality clinical execution.

02

Diverse Patient Access

CenExel sites recruit broad and diverse patient populations for improved enrollment performance.

03

Advanced Recruitment

Precision targeting and digital outreach help accelerate recruitment timelines for GI trials.

04

Reliable Study Delivery

Our operational teams ensure accurate data collection, compliance, and streamlined study management.

Phase Coverage

Supported IBS Trial Phases

CenExel supports early and late phase gastrointestinal research — from first-in-human studies through Phase IV post-market trials.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our IBS research capabilities include biomarker studies, patient-reported outcome assessments, gut microbiome evaluations, and long-term therapeutic monitoring.

Let’s Advance Your Next Study

Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.

Explore Our Network

Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.

Our Blog